| View |
|
DR-XY41218
|
METHYL SALICYLATE + MENTHOL + EUGENOL
|
ULTRA-RUB
|
102 mg/ 54.40 mg/ 13.60 mg per g
|
Cream
|
Topical Analgesics
|
The United Drug (1996) Co., Ltd.
|
Thailand
|
Renewal
|
10 August 2022
|
10 December 2027
|
| View |
|
DR-XY41219
|
Amisulpride
|
Amiabel
|
200 mg
|
Film-Coated Tablet
|
Antipyschotics (Benzamides)
|
Amherst Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
08 September 2022
|
19 September 2027
|
| View |
DR-XY41226_PI_01.pdf
|
DR-XY41226
|
Nilotinib (As Hydrochloride Monohydrate)
|
Tasigna
|
150 mg
|
Capsule
|
-
|
Novartis Pharma Stein AG
|
Switzerland
|
-
|
29 September 2020
|
26 November 2025
|
| View |
|
DR-XY41234
|
Calcium Sennosides
|
Slimbalance
|
13.34mg
|
Film-Coated Tablet
|
Laxative
|
Hua-shin Chemical Pharmaceutical Work. Co., Ltd.
|
Taiwan
|
Automatic Renewal
|
12 September 2022
|
11 September 2027
|
| View |
|
DR-XY41243
|
Allopurinol
|
Aurinol
|
100mg
|
Tablet
|
Antigout
|
Pharmasant Laboratories Co., Ltd.
|
Thailand
|
Automatic Renewal (Revalidation)
|
22 February 2022
|
13 September 2027
|
| View |
|
DR-XY41244
|
Balanced Multiple Maintenance Solution With 5% Dextrose (For Pedia)
|
Endusol-Imb
|
Formulation: Each 500 mL contains:
Electrolytes in 500 ml: Dextrose Monohydrate
Sodium 125 mmol Sodium Acetate, Anhydrous
Potassium 10 mmol Potassium Chloride
705 mg
Magnesium 0.75 mmol Sodium Phosphate Monobasic
Acetate 11.5 mmol Magnesium Chloride Hexahydrate 152.5 mg Chloride 11 mmol Monopotassium Phosphate
Phosphate 1.5 mmol Sodium Metabisulfite Water for Injection
q.s. 500 ml
945 mg
107 mg
75 mg 100 mg
Each 100 mL contains: Dextrose Monohydrate Sodium Acetate, Anhydrous Potassium Chloride Sodium Phosphate Monobasic Magnesium Chloride Hexahydrate Monopotassium Phosphate Sodium Metabisulfite (approx.. 1. Immol/L)
5g 189 mg 141 mg 21.4 mg 30.5 mg 15 mg 20 mg
Electrolytes in 1000 mL Sodium 25 mmol Potassium 20 mmol Magnesium 1.5 mmol Acetate 23 mmol Chloride 22 mmol Phosphate 3 mmol
|
Solution For Intravenous Infusion
|
Rehydration Solutions
|
Shanxi Nuocheng Pharm'l Co., Ltd.
|
China
|
Automatic Renewal
|
28 September 2022
|
13 September 2027
|
| View |
|
DR-XY41245
|
Hydroquinone
|
Dominakrem
|
40 mg
|
Topical Cream
|
Other Dermatological
|
Phil Inter Pharma Co., Ltd.
|
Vietnam
|
Automatic Renewal
|
22 September 2022
|
13 September 2027
|
| View |
|
DR-XY41252
|
Esomeprazole (As Magnesium)
|
Nexpro-40
|
40 mg
|
Enteric-Coated Tablet
|
PROTON PUMP INHIBITOR
|
Torrent Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
08 July 2022
|
19 September 2027
|
| View |
|
DR-XY41253
|
Gemcitabine (As Hydrochloride)
|
Gembio
|
1g
|
Lyophilized Powder for IV Infusion
|
-
|
Intas Pharmaceuticals Ltd.
|
India
|
-
|
24 February 2021
|
19 September 2025
|
| View |
|
DR-XY41254
|
Gemcitabine (As Hydrochloride)
|
Gembio
|
200mg
|
Lyophilized Powder for IV Infusion
|
-
|
Intas Pharmaceuticals Ltd.
|
India
|
-
|
16 February 2021
|
19 September 2025
|
| View |
|
DR-XY41255
|
5% Dextrose In 0.3% Sodium Chloride
|
None
|
None
|
Solution For Intravenous Infusion
|
Rehydration Solutions
|
Shanxi Nuocheng Pharm'l Co., Ltd.
|
China
|
Automatic Renewal
|
28 September 2022
|
19 September 2027
|
| View |
|
DR-XY41256
|
Ketamine (As Hydrochloride)
|
Etamine
|
50 mg/mL
|
Solution For Injection
|
General Anesthetic
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Automatic Renewal
|
05 September 2022
|
19 September 2027
|
| View |
|
DR-XY41257
|
Azelastine Hydrochloride
|
Astenzyd
|
1 mg/mL (137 mcg/0.137 mL per spray)
|
Solution for Nasal Spray
|
Antihistamine
|
Cadila Healthcare Limited
|
India
|
Renewal
|
22 August 2022
|
01 October 2027
|
| View |
|
DR-XY41260
|
0.9% Sodium Chloride
|
None
|
900mg/ 100mL
|
Solution For IV Infusion
|
-
|
General Hospital Products Public Co. Ltd.
|
Thailand
|
-
|
24 July 2020
|
12 December 2026
|
| View |
|
DR-XY41262
|
Naftazone
|
Mediaven Forte
|
30 mg
|
Film-Coated Tablet
|
Vasoprotective (Capillary Stabilizing Agent)
|
Haupt Pharma Berlin GmbH
|
Germany
|
Initial (from Monitored Release Extension)
|
27 May 2022
|
01 October 2025
|
| View |
|
DR-XY41264
|
Benzydamine hydrochloride + Chlorhexidine gluconate.
|
Difflam-C
|
22.5 mg/18 mg per 15 mL
|
Solution
|
Non-Steroidal Anti-Inflammatory Drug (NSAID) /
Antiseptic
|
Ensign Laboratories Pty. Ltd.
|
Australia
|
Turned Initial
|
28 May 2024
|
28 May 2029
|
| View |
|
DR-XY41267
|
Esomeprazole (As Magnesium)
|
Nexpro-20
|
20 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Torrent Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
21 July 2022
|
08 October 2027
|
| View |
|
DR-XY41273
|
Potassium Chloride 10 Meq (20 Meq/L) In 5% Dextrose And 0.33% Sodium Chloride Solution For I.V. Infusion
|
None
|
None
|
Solution For I.V. Infusion
|
Electrolyte Replenisher
|
Baxter Healthcare Philippines Inc.
|
Philippines
|
Automatic Renewal
|
03 November 2022
|
28 September 2027
|
| View |
|
DR-XY41274
|
Bupivacaine Hydrochloride
|
Bupitroy Heavy
|
5mg/mL (0.5% w/v)
|
Solution for Spinal Injection
|
Anesthetic (Amide)
|
Troikaa Pharmaceuticals Ltd.
|
India
|
Renewal
|
05 August 2022
|
28 September 2027
|
| View |
|
DR-XY41277
|
Pantoprazole (as sodium sesquihydrate)
|
Pantokem
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
ALKEM LABORATORIES LIMITED
|
India
|
Renewal
|
17 August 2022
|
28 September 2027
|